Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got a fair number of data readouts for a summer Tuesday, so let’s get right into it.

Amylyx reports success in a pivotal trial

Amylyx this morning said that, in a pivotal trial, its experimental drug significantly helped patients who experience sudden drops in blood sugar after bariatric surgery.

Continue to STAT+ to read the full story…